Tyrosine kinase inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S277000

Reexamination Certificate

active

07470696

ABSTRACT:
The present invention provides compounds of formula Iand pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents.

REFERENCES:
patent: 6465484 (2002-10-01), Bilodeau et al.
patent: 2002/0103230 (2002-08-01), Renhowe et al.
patent: 3722992 (1989-01-01), None
patent: 1300396 (2003-04-01), None
patent: 63-230687 (1988-09-01), None
patent: WO 01/96308 (2001-12-01), None
patent: WO 02/079192 (2002-10-01), None
patent: WO 03047577 (2003-06-01), None
Wassmann et al., Circulation, 2002, 105, pp. 2083-2091.
Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Science (1999), vol. 286, 531-537.
U.S. Appl. No. 10/263,448, filed Oct. 2, 2002, Wittman et al.
U.S. Appl. No. 10/674,098, filed Sep. 29, 2003, Velaparthi et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Tyrosine kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tyrosine kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tyrosine kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4043326

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.